Jayant Agro Organics Ltd (JAYAGROGN)
🎯 Key Takeaways
- Jayant Agro Organics Ltd is navigating a turnaround phase marked by declining top-line performance and margin pressure, despite stable promoter holding and governance upgrades. The company has seen sequential revenue recovery in Q1FY27 but remains below pre-decline levels, with profitability improving modestly from a low base.
- Revenue grew 23.2% QoQ to ₹797 in Q1FY27.
- ⚠️ Sustained revenue growth remains unproven, with top-line still below pre-decline levels and reliant on sequential recovery.
- Market Cap
- ₹694
- P/E Ratio
- 12.8
- P/B Ratio
- 1.14
- ROE
- 8.9%
- ROCE
- 12.7%
- Debt/Equity
- 0.22
- Div Yield
- 1.51%
- Promoter
- 67.1%
📖 The Story
Jayant Agro Organics Ltd is navigating a turnaround phase marked by declining top-line performance and margin pressure, despite stable promoter holding and governance upgrades. The company has seen sequential revenue recovery in Q1FY27 but remains below pre-decline levels, with profitability improving modestly from a low base. Management is focused on operational stabilization and leadership reinforcement, signaling a cautious but structured recovery effort.
📰 What's Happening
In Q1FY27, the company reported revenue of ₹579.79 Cr, up from ₹500 Cr in Q4FY25, indicating early signs of demand stabilization. Net profit rose to ₹13.83 Cr from ₹9 Cr in Q3FY25, reflecting cost control and operational efficiency. Concurrently, the board approved leadership changes including the appointment of Nilesh Bhadrakumar Shah as an additional independent director and the re-designation of Dinesh Kapadia as Whole-Time Director, alongside Krunal Veni’s elevation to Company Secretary and KMP. These moves, disclosed in multiple board meeting filings on July 31, 2026, aim to strengthen governance and compliance oversight. The company also announced its 34th AGM for September 12, 2026, with a proposed 70% dividend of ₹3.50 per share, pending shareholder approval.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 500 | 587 | 647 | 797 |
| Operating Profit | 17 | 12 | 28 | 33 |
| OPM % | 3.4% | 2.1% | 4.3% | 4.2% |
| Net Profit | 9 | 6 | 20 | 21 |
| EPS | ₹3.22 | ₹2.31 | ₹5.89 | ₹6.69 |
Revenue has shown sequential improvement from ₹500 Cr in Q4FY25 to ₹579.79 Cr in Q1FY27, though still down 19% YoY from ₹716 Cr in Q1FY25. Operating profit margin expanded slightly to 4.64% in Q3FY25 from 2.1% in Dec 2025, suggesting margin recovery is underway but remains fragile. Net profit rose to ₹13.83 Cr in Q3FY25 from ₹6 Cr in Dec 2025, indicating better cost management. However, the company continues to face pressure from lower revenue volumes, and the modest OPM improvement reflects ongoing challenges in scaling profitability. The financial trajectory suggests stabilization rather than growth, with management implicitly relying on operational discipline to sustain margins.
🔮 Management Outlook & What's Next
Management has not provided explicit forward guidance on revenue or margin targets in the latest filings. However, the board’s actions — particularly the emphasis on governance upgrades and leadership continuity — suggest a focus on operational resilience and stakeholder confidence. The appointment of an experienced independent director with portfolio management background is likely intended to support strategic oversight as the company navigates a challenging demand environment. No specific growth initiatives or market expansion plans were disclosed in the recent announcements.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 15 | 15 | 15 | 15 |
| Reserves | 562 | 535 | 595 | 574 |
| Borrowings | 106 | 255 | 131 | 191 |
| Total Liabilities | 869 | 978 | 982 | 943 |
| Fixed Assets | 316 | 289 | 328 | 310 |
| Investments | 13 | 12 | 11 | 13 |
| Total Assets | 869 | 978 | 982 | 943 |
The balance sheet shows a stable capital structure with low debt (Borrowings at ₹131 Cr in Mar 2026, down from ₹191 Cr in Mar 2025) and strong equity base. Reserves have grown to ₹595 Cr, indicating retained earnings are being preserved despite modest profitability. Total assets rose to ₹982 Cr in Mar 2026 from ₹869 Cr in Mar 2025, reflecting asset base expansion. The company is not aggressively investing or deleveraging but maintaining a conservative financial posture, with capital allocation focused on sustaining operations and supporting governance upgrades rather than large-scale capex or shareholder returns beyond dividends.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | +118 |
| Investing | -28 |
| Financing | -93 |
| Net Cash Flow | -3 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 67.1% | 67.1% | 67.1% | 67.1% |
| FII | 0.0% | 0.0% | 0.0% | 0.1% |
| DII | 0.0% | 0.0% | 0.0% | 0.0% |
| Public | 22.5% | 22.4% | 22.4% | 22.5% |
| # Shareholders | 13,544 | 13,203 | 12,863 | 12,572 |
Promoter holding remains stable at 67.13% across all recent quarters, indicating no signs of stake sale. Institutional interest is minimal, with FII holding at just 0.06% in Q1FY27 and DII at 0.02%, suggesting limited institutional appetite or coverage. The number of public shareholders has gradually increased to 12,572 in Q1FY27 from 12,544 in Q4FY26, reflecting retail investor engagement but no significant institutional accumulation. There are no indications of activist activity or major ownership shifts.
⚖️ Peer Comparison — Chemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| PIDILITIND | 1.53 L Cr | 57.6 | 33.4% | — | 0.01 |
| SRF | 73,810 | 34.1 | 15.6% | — | 0.36 |
| LINDEINDIA | 52,814 | 96.7 | 17.5% | — | 0.00 |
| FLUOROCHEM | 48,774 | 79.7 | 9.6% | — | 0.34 |
| NAVINFLUOR | 43,256 | 54.7 | 22.2% | — | 0.31 |
| GODREJIND | 36,153 | 30.8 | 9.2% | — | 4.57 |
| HSCL | 33,807 | 42.0 | 20.7% | — | 0.16 |
| AETHER | 23,029 | 97.7 | 13.8% | — | 0.08 |
| DEEPAKNTR | 21,155 | 27.0 | 15.3% | — | 0.26 |
| CASTROLIND | 19,891 | 18.7 | 76.2% | — | 0.00 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Sustained revenue growth remains unproven, with top-line still below pre-decline levels and reliant on sequential recovery. 2. Margin improvement is fragile, as OPM remains below historical levels and vulnerable to input cost pressures or demand softness. 3. Low institutional ownership may limit liquidity and analyst coverage, potentially affecting valuation resilience. 4. Governance changes are positive but do not directly address core operational challenges; execution will be key.
📋 Recent Filings
- Board Meeting2026-09-28The filing announces the closure of the trading window for insider trading compliance, effective from October 1, 2026, covering the quarter ending Sep…
- 🟡 Board Meeting2026-09-12Jayant Agro Organics held its 34th AGM on September 12, 2026 via video conference, adopting audited standalone and consolidated financial statements f…
- 🟡 voting results2026-09-12At the 34th Annual General Meeting held on September 12, 2026 via video conference, all proposed resolutions were approved by shareholders, meeting th…
- 🔴 Financial Results2026-08-01Jayant Agro Organics Limited announced unaudited financial results for the quarter ended June 30, 2026 via newspaper advertisements in Business Standa…
- 🔴 Financial Results2026-07-31Jayant Agro Organics announced board approval of unaudited Q1 FY26 financial results and key leadership changes effective July 31, 2026. Mr. Nilesh Bh…
- 🟡 Board Meeting2026-07-31Jayant Agro Organics announced its 34th Annual General Meeting will be held on September 12, 2026 via video conference, with a record date and dividen…
- 🟡 Board Meeting2026-07-31The board approved unaudited Q1 FY26 results, appointed Nilesh Shah as an additional independent director for 5 years starting July 31, 2026, and re-d…
- 🔴 Financial Results2026-07-31Jayant Agro Organics announced board decisions on July 31, 2026 including approval of unaudited Q1FY27 financial results, appointment of Nilesh Bhadra…
- 🔴 Corporate Action2026-07-30Jayant Agro Organics announced August 7, 2026 as the record date for its AGM and dividend eligibility, with a proposed 70% final dividend of Rs 3.50 p…
- share transfer2026-07-06Jayant Agro Organics received a SEBI-mandated share transfer certificate from MUFG Intime confirming dematerialization of securities for the quarter e…
🧠 Analyst's Read
Jayant Agro Organics is in a stabilization phase, with management focusing on governance and incremental operational recovery rather than transformative growth. Investors should monitor whether revenue momentum sustains and whether margin improvements hold amid competitive and demand pressures. The upcoming AGM and dividend declaration are near-term catalysts, but long-term trajectory depends on execution of operational plans beyond governance reforms.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-29.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when JAYAGROGN files new disclosures
Track JAYAGROGN filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track JAYAGROGN — FreeFree account · 2 AI queries/day